Phase I Study Evaluating Tolerability, Safety, Pharmacokinetics, and Efficacy of Combined ONO-4059 and R-MPV Therapy for PCNSL

Nagoya, Aichi-ken, Japan

Nagoya, Aichi-ken, Japan

Akita, Akita, Japan

Urayasu-shi, Chiba, Japan

Fukuoka, Fukuoka, Japan

Fukuoka, Fukuoka, Japan

Kitakyushu-shi, Fukuoka, Japan

Kurume-shi, Fukuoka, Japan

Fukushima, Fukushima, Japan

Gifu, Gifu, Japan

Maebashi, Gunma, Japan

Sapporo, Hokkaido, Japan

Kobe, Hyōgo, Japan

Nishinomiya-shi, Hyōgo, Japan

Tsukuba, Ibaraki, Japan

Kahoku-gun, Ishikawa-ken, Japan

Kita-gun, Kagawa-ken, Japan

Kawasaki-shi, Kanagawa, Japan

Yokohama, Kanagawa, Japan

Nankoku-shi, Kochi, Japan

Miyazaki, Miyazaki, Japan

Nagasaki, Nagasaki, Japan

Ikoma-shi, Nara, Japan

Kashihara-shi, Nara, Japan

Niigata, Niigata, Japan

Yufu-shi, Oita Prefecture, Japan

Kurashiki-shi, Okayama-ken, Japan

Osaka, Osaka, Japan

Osakasayama-shi, Osaka, Japan

Suita-shi, Osaka, Japan

Saga, Saga-ken, Japan

Kawagoe-shi, Saitama, Japan

Sunto-gun, Shizuoka, Japan

Shimotsuga-gun, Tochigi, Japan

Bunkyo-ku, Tokyo, Japan

Koto-ku, Tokyo, Japan

Midorichō, Tokyo, Japan

Minato-ku, Tokyo, Japan

Minato-ku, Tokyo, Japan

Shinjuku-ku, Tokyo, Japan

Shinjuku-ku, Tokyo, Japan

Toyama, Toyama, Japan

Ube-shi, Yamaguchi, Japan

Chuo-shi, Yamanashi, Japan